Literature DB >> 31306591

Transplantation of Aggregates of Autologous Synovial Mesenchymal Stem Cells for Treatment of Cartilage Defects in the Femoral Condyle and the Femoral Groove in Microminipigs.

Shimpei Kondo1, Yusuke Nakagawa1,2, Mitsuru Mizuno2, Kenta Katagiri1, Kunikazu Tsuji3, Shinji Kiuchi4, Hideo Ono4, Takeshi Muneta5, Hideyuki Koga1, Ichiro Sekiya2.   

Abstract

BACKGROUND: Previous work has demonstrated that patients with cartilage defects of the knee benefit from arthroscopic transplantation of autologous synovial mesenchymal stem cells (MSCs) in terms of magnetic resonance imaging (MRI), qualitative histologic findings, and Lysholm score. However, the effectiveness was limited by the number of cells obtained, so large-sized defects (>500 mm2) were not investigated. The use of MSC aggregates may enable treatment of larger defects by increasing the number of MSCs adhering to the cartilage defect.
PURPOSE: To investigate whether transplantation of aggregates of autologous synovial MSCs with 2-step surgery could promote articular cartilage regeneration in microminipig osteochondral defects. STUDY
DESIGN: Controlled laboratory study.
METHODS: Synovial MSCs derived from a microminipig were examined for in vitro colony-forming and multidifferentiation abilities. An aggregate of 250,000 synovial MSCs was formed with hanging drop culture, and 16 aggregates (for each defect) were implanted on both osteochondral defects (6 × 6 × 1.5 mm) created in the medial femoral condyle and femoral groove (MSC group). The defects in the contralateral knee were left empty (control group). The knee joints were evaluated at 4 and 12 weeks by macroscopic findings and histology. MRI T1rho mapping images were acquired at 12 weeks. For cell tracking, synovial MSCs were labeled with ferucarbotran before aggregate formation and were observed with MRI at 1 week.
RESULTS: Synovial MSCs showed in vitro colony-forming and multidifferentiation abilities. Regenerative cartilage formation was significantly better in the MSC group than in the control group, as indicated by International Cartilage Repair Society score (macro), modified Wakitani score (histology), and T1rho mapping (biochemical MRI) in the medial condyle at 12 weeks. Implanted cells, labeled with ferucarbotran, were observed in the osteochondral defects at 1 week with MRI. No significant difference was noted in the modified Wakitani score at 4 weeks in the medial condyle and at 4 and 12 weeks in the femoral groove.
CONCLUSION: Transplantation of autologous synovial MSC aggregates promoted articular cartilage regeneration at the medial femoral condyle at 12 weeks in microminipigs. CLINICAL RELEVANCE: Aggregates of autologous synovial MSCs could expand the indications for cartilage repair with synovial MSCs.

Entities:  

Keywords:  aggregate; articular cartilage regeneration; mesenchymal stem cell; microminipig; synovium

Mesh:

Year:  2019        PMID: 31306591     DOI: 10.1177/0363546519859855

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  10 in total

1.  Human integrin α10β1-selected mesenchymal stem cells home to cartilage defects in the rabbit knee and assume a chondrocyte-like phenotype.

Authors:  Camilla Andersen; Kristina Uvebrant; Yuki Mori; Stacie Aarsvold; Stine Jacobsen; Lise Charlotte Berg; Evy Lundgren-Åkerlund; Casper Lindegaard
Journal:  Stem Cell Res Ther       Date:  2022-05-16       Impact factor: 8.079

2.  Exosomes: roles and therapeutic potential in osteoarthritis.

Authors:  Zhenhong Ni; Siru Zhou; Song Li; Liang Kuang; Hangang Chen; Xiaoqing Luo; Junjie Ouyang; Mei He; Xiaolan Du; Lin Chen
Journal:  Bone Res       Date:  2020-06-19       Impact factor: 13.567

3.  Exosomes: roles and therapeutic potential in osteoarthritis.

Authors:  Zhenhong Ni; Siru Zhou; Song Li; Liang Kuang; Hangang Chen; Xiaoqing Luo; Junjie Ouyang; Mei He; Xiaolan Du; Lin Chen
Journal:  Bone Res       Date:  2020-06-19       Impact factor: 13.567

Review 4.  Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application.

Authors:  Kangkang Zha; Xu Li; Zhen Yang; Guangzhao Tian; Zhiqiang Sun; Xiang Sui; Yongjing Dai; Shuyun Liu; Quanyi Guo
Journal:  NPJ Regen Med       Date:  2021-03-19

5.  Pneumatospinning Biomimetic Scaffolds for Meniscus Tissue Engineering.

Authors:  Erik W Dorthé; Austin B Williams; Shawn P Grogan; Darryl D D'Lima
Journal:  Front Bioeng Biotechnol       Date:  2022-02-02

6.  Injectable adipose-derived stem cells-embedded alginate-gelatin microspheres prepared by electrospray for cartilage tissue regeneration.

Authors:  Sida Liao; Haoye Meng; Jun Zhao; Wancheng Lin; Xiuzhi Liu; Zhuang Tian; Lan Lan; Hanyu Yang; Yulan Zou; Yichi Xu; Xiao Gao; Shibi Lu; Jiang Peng
Journal:  J Orthop Translat       Date:  2022-04-11       Impact factor: 4.889

Review 7.  Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models.

Authors:  Timothy P Liu; Pin Ha; Crystal Y Xiao; Sang Yub Kim; Andrew R Jensen; Jeremiah Easley; Qingqiang Yao; Xinli Zhang
Journal:  Front Cell Dev Biol       Date:  2022-09-06

Review 8.  The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation.

Authors:  Han Yin; Muzhe Li; Guangzhao Tian; Yang Ma; Chao Ning; Zineng Yan; Jiang Wu; Qian Ge; Xiang Sui; Shuyun Liu; Jinxuan Zheng; Weimin Guo; Quanyi Guo
Journal:  Biomater Res       Date:  2022-10-05

9.  Effect of CD44 signal axis in the gain of mesenchymal stem cell surface antigens from synovial fibroblasts in vitro.

Authors:  Masaaki Isono; Jun Takeuchi; Ami Maehara; Yusuke Nakagawa; Hiroki Katagiri; Kazumasa Miyatake; Ichiro Sekiya; Hideyuki Koga; Yoshinori Asou; Kunikazu Tsuji
Journal:  Heliyon       Date:  2022-09-28

Review 10.  Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases.

Authors:  Na Li; Jinfang Gao; Liangyu Mi; Gailian Zhang; Liyun Zhang; Na Zhang; Rongxiu Huo; Junping Hu; Ke Xu
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.